Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Roy L. McQuinn"'
Autor:
Vicki L. Horton, Gregory J. Quarfoth, Paula E. Blegen, Thomas H. Barrows, James D. Johnson, Sheila J. Gibson, Roy L. McQuinn
Publikováno v:
Progress in Biomedical Polymers ISBN: 9781489907707
Poly(ester-amides) (PEA) are a class of bioabsorbable polymers with potential biomedical applications. To evaluate the in vivo degradation and elimination routes of these polymers, rats were implanted with a carbon-14 labeled monomer precursor, C6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1205e505fa3d5fb8a2fd5bdc5e97f4ca
https://doi.org/10.1007/978-1-4899-0768-4_27
https://doi.org/10.1007/978-1-4899-0768-4_27
Publikováno v:
Synthetic Communications. 9:25-30
Nitroso compounds are receiving a great deal of attention lately as potential carcinogenic agents and also as carcinostatic agents. There are numerous reports in the current literature that attest to the potent mutagenic and carcinogenic effects prod
Autor:
James C. Perry, Roy L. McQuinn, Richard T. Smith, Arthur Garson, Cheryl Gothing, Patricia Fredell
Publikováno v:
Journal of the American College of Cardiology. 14(1):185-191
Drug efficacy and pharmacokinetics were assessed in 63 patients, aged 5 days to 30 years (mean 8 years), who received flecainide acetate for control of resistant arrhythmias. Doses of flecainide ranged from 59 to 225 mg/m2 body surface area per day (
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 5:1577-1580
Recent reports have suggested that vitamin A, a recognized membrane-active agent, enhances the antitumor effect of certain lipid nitrosoureas in marine L1210 leukemia, when used as a pretreatment agent. A possible explanation may involve enhanced upt
Autor:
Roy L. McQuinn, Donald A. Berry, Donald C Kvam, Denise Finley, L. Mottonen, Bruce P Ekholm, A. M. Miller, Jordan L. Holtzman
Publikováno v:
Clinical pharmacology and therapeutics. 46(1)
Flecainide and verapamil are antiarrhythmic agents that may be used in combination. We have examined their pharmacodynamic interaction by M-mode echocardiography and electrocardiography in eight normal male volunteers (24 +/- 1.8 years of age). Fleca
Autor:
Roy L. McQuinn, Ralph E. Cutler, Gordon J. Conard, A. M. Miller, S. Parish, Don C. Kvam, Steven C. Forland
Publikováno v:
Journal of clinical pharmacology. 28(8)
Study objective: To determine the pharmacokinetics of oral flecainide acetate after single and multiple doses in patients with impaired renal function. Design: Paired study of single followed by multiple oral doses. Setting: Patients enrolled in a Ve
Publikováno v:
Journal of cardiovascular pharmacology. 12(4)
Flecainide acetate is a recently approved class 1c antiarrhythmic agent indicated for patients with serious ventricular arrhythmias. Because flecainide may be used in patients with automatic implantable defibrillators, we assessed the effect of fleca
Publikováno v:
Journal of chromatography. 431(2)